What Is PCV 13?
Developed by the American pharmaceutical company Pfizer, PCV13 is a type of pneumococcal vaccine which covers the 13 most common serotypes with a coverage of up to 70%. It is the conjugate vaccine with the highest coverage, covering the most resistant serotypes 3, 6A and 19A. PCV13 prevents pneumococcal diseases, including pneumonia, otitis media (temporary / permanent deafness), septicemia (bacterial invasion) and meningitis (which may cause blindness and impaired brain function).
Related FAQs:
The Lancet Declared 20Kg Weight Loss Could Reverse Type 2 Diabetes. Is It A Rumor ?
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.